Drug retention rates and treatment outcomes in 1860 axial spondyloarthritis patients treated with Secukinumab in routine clinical practice in 13 European countries in the EUROSPA Research Collaboration Network
14/08/2023
B. Michelsen1, U. Lindström1, C. Codreanu1, A. Ciurea1, J. Zavada1, A. G. Loft1, M. Pombo-Suarez1, F. Onen1, T. K. Kvien1, Z. Rotar1, M. J. Santos1, F. Iannone1, A. M. Hokkanen1, B. Gudbjornsson1, J. Askling1, R. Ionescu1, M. Nissen1, K. Pavelka1, C. Sánchez-Piedra1, S. Akar1, J. Sexton1, M. Tomsic1, H. Santos1, M. Sebastiani1, J. Osterlund1, A. J. Geirsson1, G. T. Jones1, I. Van der Horst-Bruinsma1, S. Georgiadis1, C. H. Brahe1, L. Midtbøll Ørnbjerg1, M. L. Hetland1, M. ?stergaard1
EULAR 2020
Ann Rheum Dis, volume 79, supplement 1, year 2020, page 431
http://scientific.sparx-ip.net/archiveeular/?c=a&view=1&searchfor=sanchez-piedra&item=2020THU0398